Drug/chemical-induced diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema in the right eye is a condition resulting from the adverse effects of certain medications or chemicals on glucose metabolism. This condition is clinically significant as it can lead to vision impairment and requires careful monitoring and management. The ICD-10 Code E09.3391 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively track and manage this complication.
ICD-10 Code E09.3391 represents drug or chemical-induced diabetes mellitus characterized by moderate nonproliferative diabetic retinopathy without macular edema in the right eye. This code should be used when documenting cases where diabetes is a result of pharmacological agents, and it is essential for accurate clinical documentation and billing, particularly in cases where the retinopathy is present but not severe enough to involve macular edema.
Drug/chemical-induced diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema in the right eye is primarily caused by the impact of certain medications on insulin sensitivity and glucose metabolism. This condition can progress to more severe forms of retinopathy if not managed appropriately, necessitating medical attention.
ICD-10 Code E09.3391 is utilized in SOAP notes to document the presence of drug-induced diabetes and its associated complications. This code aids in the systematic recording of symptoms, assessments, and treatment plans, ensuring comprehensive care in both acute and chronic settings.
In SOAP notes, ICD-10 Code E09.3391 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of drug-induced diabetes with associated retinopathy. This code is crucial for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Management of drug-induced diabetes with moderate nonproliferative diabetic retinopathy requires a multifaceted approach to prevent progression and manage symptoms.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code E09.3391 is essential for accurate billing in hospital, ER, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 99213 | Established patient office visit, moderate complexity. |
| 92014 | Ophthalmological examination, established patient. |
| 83036 | Hemoglobin A1c test for diabetes management. |
Common Questions About Using ICD-10 Code E09.3391 for Drug/chem diab with mod nonp rtnop without mclr edema, r eye
What medications can cause drug-induced diabetes?
Certain medications, including corticosteroids, antipsychotics, and some antihypertensives, can lead to drug-induced diabetes by affecting insulin sensitivity and glucose metabolism.
How is diabetic retinopathy diagnosed?
Diabetic retinopathy is diagnosed through a comprehensive eye examination, including fundoscopic evaluation, which assesses the retina for signs of damage.
What are the treatment options for diabetic retinopathy?
Treatment options for diabetic retinopathy may include laser therapy, anti-VEGF injections, and careful management of blood glucose levels to prevent progression.
Is drug-induced diabetes reversible?
In some cases, drug-induced diabetes may be reversible if the offending medication is discontinued and blood glucose levels are managed effectively.
Clinical Notes
SOAP notes
DAP notes
AI medical notes